GB980276A - Composition intended primarily for the treatment of hypercholesterolaemia - Google Patents

Composition intended primarily for the treatment of hypercholesterolaemia

Info

Publication number
GB980276A
GB980276A GB14403/63A GB1440363A GB980276A GB 980276 A GB980276 A GB 980276A GB 14403/63 A GB14403/63 A GB 14403/63A GB 1440363 A GB1440363 A GB 1440363A GB 980276 A GB980276 A GB 980276A
Authority
GB
United Kingdom
Prior art keywords
divanillidene
treatment
hypercholesterolaemia
acid
cholagogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14403/63A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EGEMA
Original Assignee
EGEMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EGEMA filed Critical EGEMA
Publication of GB980276A publication Critical patent/GB980276A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A composition which may be used in the treatment of cholesterolemia, atherosclerosis, hyperazotemia and obesity comprises in admixture 3 : 5 - diiodo - 4 - (31 - iodo - 41 - hydroxyphenoxy)-phenylacetic acid or a salt of this acid, Vitamin A and a compatible cholagogue or choleretic agent. The Vitamin A may be in the form of the alcohol, palmitate or acetate. The cholagogue or choleretic agent may be a derivative of vanillic acid or of its salts, e.g. divanillidene cyclohexanone, divanillidene ethylene diamine, vanillidene malonyl ester, divanillidene diaminodiphenyl or diveratrylidene cyclohexanone; or a substance of natural origin extracted from plants, e.g. curcuma.
GB14403/63A 1962-04-12 1963-04-10 Composition intended primarily for the treatment of hypercholesterolaemia Expired GB980276A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR894235A FR1867M (en) 1962-04-12 1962-04-12 New composition intended in particular for the treatment of cholesterolemia.

Publications (1)

Publication Number Publication Date
GB980276A true GB980276A (en) 1965-01-13

Family

ID=8776714

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14403/63A Expired GB980276A (en) 1962-04-12 1963-04-10 Composition intended primarily for the treatment of hypercholesterolaemia

Country Status (2)

Country Link
FR (1) FR1867M (en)
GB (1) GB980276A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007330A1 (en) * 1989-01-06 1990-07-12 The Regents Of The University Of California Selection method for specific useful pharmaceutical compounds

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788991A (en) * 1971-09-20 1973-03-19 Lilly Co Eli ARYLIDENE CYCLANONES AND METHOD OF USE OF THEM IN THE INHIBITION OF THE ACTION OF ANDROGENS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007330A1 (en) * 1989-01-06 1990-07-12 The Regents Of The University Of California Selection method for specific useful pharmaceutical compounds
WO1990007329A1 (en) * 1989-01-06 1990-07-12 The Regents Of The University Of California Selection method for pharmacologically active compounds

Also Published As

Publication number Publication date
FR1867M (en) 1963-06-17

Similar Documents

Publication Publication Date Title
JPS5294433A (en) Perfume blender
AR202629A1 (en) ESTER OF CYCLOPROPROPANOCARBOXYL ACID, PROCESS FOR ITS PREPARATION AND INSECTICIDE COMPOSITIONS CONTAINING IT
GB980276A (en) Composition intended primarily for the treatment of hypercholesterolaemia
Hull et al. Rathus Assertiveness Schedule: normative and factor-analytic data
AR215125A1 (en) COMPOSITION TO BE INGESTED BY ANIMALS, CONTAINING AN AGENT TO IMPROVE THE USE OF NUTRITIVE SUBSTANCES AND GROWTH FOR RUMIANTS AND SPECIES OF ANIMALS WITH SIMILAR DIGESTIVE PHYSIOLOGY AND PROCEDURE AND CONCENTRATE TO PREPARE IT
FR2042379A1 (en) Vitamin a preparations for veterinary injec - tions
JPS5241223A (en) Method of attracting and killing termites
GB1038908A (en) Insect chemosterilant
GB949400A (en) Poliomyelitis vaccines
SAKATO et al. STUDIES ON A PISCICIDAL CONSTITUENT OF HURA CREPITANS: I. ISOLATION AND CHARACTERIZATION OF HURATOXIN AND ITS PISCICIDAL ACTIVITY
AT205667B (en) Process for the production of an easily digestible chocolate preparation with therapeutic effect
GB824912A (en) Vitamin e composition
JPS5587714A (en) Anti-suntan agent
JPS5257212A (en) Homogenizing process of fat
JPS5592316A (en) Cholesterol-lowering agent
GB865080A (en) Compositions comprising viruses adsorbed on lipids and methods for the preparation thereof
Jinming et al. STUDY ON ANTI-OXIDATION ACTITY OF ASTAXANTHIN
GB1060353A (en) Improvements in or relating to the treatment of natural rubber latex
GB938241A (en) Pineal gland extracts
GB554824A (en) Method of separating water soluble vitamins from other water soluble materials
GB1059703A (en) 8-acyloxy-bz-tetrahydroquinolines and their preparation
AU242480B2 (en) Insecticides and method of producing the o. o - diakyl - di -thiophosphoryl fatty acid anhydrides and amides usable as active substances for these
ES287531A1 (en) Procedure for the preparation of an insecticide or large composition for use against mosquitoes (Machine-translation by Google Translate, not legally binding)
TAKIGUCHI et al. " Residual Solution" by Wheat Varnalization: Report 2. Its influence on the earing of wheat
Ram et al. In vitro effects of T-2 toxin on lipid peroxidation and release of alkaline and acid phosphatases in buffalo splenocytes.